These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 32438374)

  • 21. A comparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery.
    Kao WY; Su CW; Chau GY; Lui WY; Wu CW; Wu JC
    World J Surg; 2011 Apr; 35(4):858-67. PubMed ID: 21207029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
    Feld JJ; Krassenburg LAP
    Dig Dis Sci; 2019 Apr; 64(4):1041-1049. PubMed ID: 30874985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?
    Lok AS
    J Gastroenterol Hepatol; 2011 Feb; 26(2):221-7. PubMed ID: 21070361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma].
    Pár A
    Orv Hetil; 2009 Jan; 150(1):19-26. PubMed ID: 19091671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.
    Kumagi T; Terao T; Yokota T; Azemoto N; Kuroda T; Imamura Y; Uesugi K; Kisaka Y; Tanaka Y; Shibata N; Koizumi M; Ohno Y; Yukimoto A; Tange K; Nishiyama M; Kanemitsu K; Miyake T; Miyata H; Ishii H; Hiasa Y;
    Mayo Clin Proc; 2019 Oct; 94(10):2004-2010. PubMed ID: 31262521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in prognostic factors according to viral status in patients with hepatocellular carcinoma.
    Akahoshi H; Taura N; Ichikawa T; Miyaaki H; Akiyama M; Miuma S; Ozawa E; Takeshita S; Muraoka T; Matsuzaki T; Ohtani M; Isomoto H; Matsumoto T; Takeshima F; Nakao K
    Oncol Rep; 2010 May; 23(5):1317-23. PubMed ID: 20372846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
    Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.
    McMahon B; Block J; Block T; Cohen C; Evans AA; Hosangadi A; London WT; Sherman M;
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26626106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
    Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
    J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
    Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
    Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
    Poh Z; Goh BB; Chang PE; Tan CK
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis.
    Feuth T; Arends JE; Lieveld FI; Mundt MW; Hoepelman AI; Siersema PD; van Erpecum KJ
    Scand J Gastroenterol; 2013 Sep; 48(9):1074-81. PubMed ID: 23886398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma.
    Yang JD; Kim WR; Coelho R; Mettler TA; Benson JT; Sanderson SO; Therneau TM; Kim B; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):64-70. PubMed ID: 20831903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved Survival in Patients with Viral Hepatitis-Induced Hepatocellular Carcinoma Undergoing Recommended Abdominal Ultrasound Surveillance in Ontario: A Population-Based Retrospective Cohort Study.
    Thein HH; Campitelli MA; Yeung LT; Zaheen A; Yoshida EM; Earle CC
    PLoS One; 2015; 10(9):e0138907. PubMed ID: 26398404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.